Transition From Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Ii-Receptor-Blocker to Sacubitril/Valsartan in Chronic Heart Failure Patients: Initial Experiences in Clinical Practice
Cor et Vasa - Poland
doi 10.1016/j.crvasa.2017.10.009
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2018
Authors
Publisher
Czech Society of Cardiology